Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence.
Martin RasmussenJacob FredsøeAmy L TinAndrew J VickersBenedicte UlhøiMichael BorreJames EasthamBehfar EhdaieBertrand GuillonneauVincent LaudonePeter T ScardinoKarim TouijerKarina Dalsgaard SørensenHans G LiljaPublished in: British journal of cancer (2021)
This study validates prior investigations on the use of 4Kscore in men with biopsy-confirmed PC. Men with GG1 PC and a high 4Kscore may benefit from additional testing to guide treatment selection. Further research is warranted regarding the value of the 4Kscore in men with biopsy GG2 PC.